These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18936777)

  • 21. Examining coagulation-complement crosstalk: complement activation and thrombosis.
    Foley JH
    Thromb Res; 2016 May; 141 Suppl 2():S50-4. PubMed ID: 27207425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.
    Mandruzzato S; Solito S; Falisi E; Francescato S; Chiarion-Sileni V; Mocellin S; Zanon A; Rossi CR; Nitti D; Bronte V; Zanovello P
    J Immunol; 2009 May; 182(10):6562-8. PubMed ID: 19414811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The complement system in cancer: Ambivalence between tumour destruction and promotion.
    Mamidi S; Höne S; Kirschfink M
    Immunobiology; 2017 Jan; 222(1):45-54. PubMed ID: 26686908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine.
    Ko HJ; Lee JM; Kim YJ; Kim YS; Lee KA; Kang CY
    J Immunol; 2009 Feb; 182(4):1818-28. PubMed ID: 19201833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editorial: The Role of Complement in Tumors.
    Rolfe BE; Pio R; Woodruff TM; Markiewski MM; Manthey HD
    Front Immunol; 2020; 11():139. PubMed ID: 32117286
    [No Abstract]   [Full Text] [Related]  

  • 26. Recent progress in the understanding of complement activation and its role in tumor growth and anti-tumor therapy.
    Liu XY; Wang XY; Li RY; Jia SC; Sun P; Zhao M; Fang C
    Biomed Pharmacother; 2017 Jul; 91():446-456. PubMed ID: 28477461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Head and neck tumour immunology: basic concepts and new clinical implications.
    Topping KP; Fletcher LM; Agada FO; Alhamarneh O; Stafford ND; Greenman J
    J Laryngol Otol; 2009 Jan; 123(1):9-18. PubMed ID: 18761764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complementing Lung Cancer: How Tumor Cells Co-opt the Host Complement System to Reach Bone.
    Roman J
    Am J Respir Crit Care Med; 2018 May; 197(9):1101-1103. PubMed ID: 29365275
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter in response to A. Agrawal: 'CRP after 2004'.
    van den Berg CW; Morgan BP
    Mol Immunol; 2006 Feb; 43(3):292-3. PubMed ID: 16038977
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunological effects and therapeutic role of C5a in cancer.
    Darling VR; Hauke RJ; Tarantolo S; Agrawal DK
    Expert Rev Clin Immunol; 2015 Feb; 11(2):255-63. PubMed ID: 25387724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver regeneration: a link to inflammation through complement.
    DeAngelis RA; Markiewski MM; Lambris JD
    Adv Exp Med Biol; 2006; 586():17-34. PubMed ID: 16893062
    [No Abstract]   [Full Text] [Related]  

  • 33. Myeloid dendritic cell: From sentinel of immunity to key player of peripheral tolerance?
    Steinbrink K; Mahnke K; Grabbe S; Enk AH; Jonuleit H
    Hum Immunol; 2009 May; 70(5):289-93. PubMed ID: 19217922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A complement a day keeps the Fox(p3) away.
    Le Friec G; Köhl J; Kemper C
    Nat Immunol; 2013 Feb; 14(2):110-2. PubMed ID: 23334823
    [No Abstract]   [Full Text] [Related]  

  • 35. Complement and human T cell metabolism: Location, location, location.
    West EE; Kunz N; Kemper C
    Immunol Rev; 2020 May; 295(1):68-81. PubMed ID: 32166778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invited commentary.
    Lappegard KT
    Ann Thorac Surg; 2007 Jan; 83(1):152. PubMed ID: 17184650
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of CD4 T cell help for CD8 CTL activation.
    Zhang S; Zhang H; Zhao J
    Biochem Biophys Res Commun; 2009 Jul; 384(4):405-8. PubMed ID: 19410556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarction.
    Distelmaier K; Adlbrecht C; Jakowitsch J; Winkler S; Dunkler D; Gerner C; Wagner O; Lang IM; Kubicek M
    Thromb Haemost; 2009 Sep; 102(3):564-72. PubMed ID: 19718478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer resistance to complement-dependent cytotoxicity (CDC): Problem-oriented research and development.
    Gancz D; Fishelson Z
    Mol Immunol; 2009 Sep; 46(14):2794-800. PubMed ID: 19501402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.
    Schraufstatter IU; Discipio RG; Zhao M; Khaldoyanidi SK
    J Immunol; 2009 Mar; 182(6):3827-36. PubMed ID: 19265162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.